Haleon plc Total Liabilities

Latest as of June 2026: $16.04 Billion USD

Haleon plc total liabilities. Based on the latest financial reports, Haleon plc (HLN) has total liabilities worth $16.04 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check HLN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Haleon plc (2019–2025)

Total liabilities of Haleon plc from 2019 to 2025. This chart illustrates how Haleon plc's total liabilities have evolved over time, based on quarterly financial data.

Haleon plc Competitors by Total Liabilities

The table below lists competitors of Haleon plc ranked by their total liabilities.

Company Country Total Liabilities
Goodman Group
AU:GMG
Australia AU$8.65 Billion
Itaú Unibanco Holding S.A
F:BVXB
Germany €2.85 Trillion
Ameriprise Financial Inc
NYSE:AMP
USA $178.24 Billion
Revolution Medicines Inc
NASDAQ:RVMD
USA $1.72 Billion
AngloGold Ashanti Ltd
JSE:ANG
South Africa ZAC4.81 Billion
Bank of Communications Co. Ltd
F:C4C
Germany €14.97 Trillion
CSL LTD SPON.ADR 2
F:CSJA
Germany €17.90 Billion
JD.com Inc Adr
NASDAQ:JD
USA $443.19 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Haleon plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see HLN total assets.

Liquidity & Leverage Metrics

Haleon plc Total Liabilities Ratios Explained

Haleon plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.69 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.50 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Haleon plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Haleon plc (2019–2025)

The table below shows the annual total liabilities of Haleon plc from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 $16.12 Billion -10.91%
2024-12-31 $18.09 Billion +4.42%
2023-12-31 $17.33 Billion -5.62%
2022-12-31 $18.36 Billion +130.31%
2021-12-31 $7.97 Billion +0.81%
2020-12-31 $7.91 Billion -4.72%
2019-12-31 $8.30 Billion --

About Haleon plc

NYSE:HLN USA Drug Manufacturers - Specialty & Generic
Market Cap
$40.25 Billion
Market Cap Rank
#654 Global
#315 in USA
Share Price
$9.14
Change (1 day)
-0.11%
52-Week Range
$8.57 - $11.27
All Time High
$11.41
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more